230 related articles for article (PubMed ID: 24314067)
1. Impact of dyslipidemic components of metabolic syndrome, adiponectin levels, and anti-diabetes medications on malondialdehyde-modified low-density lipoprotein levels in statin-treated diabetes patients with coronary artery disease.
Matsuda M; Tamura R; Kanno K; Segawa T; Kinoshita H; Nishimoto O; Nishiyama H; Kawamoto T
Diabetol Metab Syndr; 2013 Dec; 5(1):77. PubMed ID: 24314067
[TBL] [Abstract][Full Text] [Related]
2. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
3. Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk.
Yanai H; Adachi H; Hakoshima M; Katsuyama H
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362288
[TBL] [Abstract][Full Text] [Related]
4. Improvement of endothelial dysfunction is mediated through reduction of remnant lipoprotein after statin therapy in patients with coronary artery disease.
Nakamura T; Uematsu M; Yoshizaki T; Kobayashi T; Watanabe Y; Kugiyama K
J Cardiol; 2020 Mar; 75(3):270-274. PubMed ID: 31500961
[TBL] [Abstract][Full Text] [Related]
5. Low-density Lipoprotein Subclasses are Associated with Serum Uric Acid Levels.
Moriyama K
Clin Lab; 2018 Jul; 64(7):1137-1144. PubMed ID: 30146836
[TBL] [Abstract][Full Text] [Related]
6. Increased circulating malondialdehyde-modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles.
Tanaga K; Bujo H; Inoue M; Mikami K; Kotani K; Takahashi K; Kanno T; Saito Y
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):662-6. PubMed ID: 11950707
[TBL] [Abstract][Full Text] [Related]
7. The Impact of CDH13 Polymorphism and Statin Administration on TG/HDL Ratio in Cardiovascular Patients.
Choi JR; Jang Y; Kim Yoon S; Park JK; Sorn SR; Park MY; Lee M
Yonsei Med J; 2015 Nov; 56(6):1604-12. PubMed ID: 26446643
[TBL] [Abstract][Full Text] [Related]
8. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
Querton L; Buysschaert M; Hermans MP
J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
[TBL] [Abstract][Full Text] [Related]
9. Circulating malondialdehyde-modified low-density lipoprotein is strongly associated with very small low-density lipoprotein cholesterol concentrations in healthy men.
Takahashi R; Imamura A; Yoshikane M; Suzuki M; Cheng XW; Numaguchi Y; Ikeda N; Murohara T; Okumura K
Clin Chim Acta; 2009 Jan; 399(1-2):74-8. PubMed ID: 18840422
[TBL] [Abstract][Full Text] [Related]
10. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
Reiner Z
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
[TBL] [Abstract][Full Text] [Related]
11. High-dose statin therapy with rosuvastatin reduces small dense LDL and MDA-LDL: The Standard versus high-dose therApy with Rosuvastatin for lipiD lowering (SARD) trial.
Nishikido T; Oyama J; Keida T; Ohira H; Node K
J Cardiol; 2016 Apr; 67(4):340-6. PubMed ID: 26162946
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol efflux and metabolic abnormalities associated with low high-density-lipoprotein-cholesterol and high triglycerides in statin-treated coronary men with low-density lipoprotein-cholesterol <70 mg/dl.
Posadas-Sánchez R; Posadas-Romero C; Mendoza-Pérez E; Caracas-Portilla NA; Cardoso-Saldaña G; Medina-Urrutia A; Jorge-Galarza E; Juárez-Rojas JG
Am J Cardiol; 2012 Mar; 109(5):636-41. PubMed ID: 22169129
[TBL] [Abstract][Full Text] [Related]
13. The Achievement of Non-high-density Lipoprotein Cholesterol Target in Patients with Very High Atherosclerotic Cardiovascular Disease Risk Stratified by Triglyceride Levels Despite Statin-controlled Low-density Lipoprotein Cholesterol.
Al-Sabti H; Al-Hinai AT; Al-Zakwani I; Al-Hashmi K; Al Mahmeed W; Arafah M; Shehab A; Al Tamimi O; Al Awadhi M; Al Herz S; Al Anazi F; Al Nemer K; Metwally O; Alkhadra A; Fakhry M; Elghetany H; Medani AR; Yusufali AH; Al Jassim O; Al Hallaq O; Baslaib FOAS; Amin H; Al-Waili K; Al-Rasadi K
Oman Med J; 2022 Mar; 37(2):e367. PubMed ID: 35449790
[TBL] [Abstract][Full Text] [Related]
14. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance is associated with increased cholesterol synthesis, decreased cholesterol absorption and enhanced lipid response to statin therapy.
Hoenig MR; Sellke FW
Atherosclerosis; 2010 Jul; 211(1):260-5. PubMed ID: 20356594
[TBL] [Abstract][Full Text] [Related]
16. Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol.
Ogita M; Miyauchi K; Miyazaki T; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Yokoyama T; Okazaki S; Kurata T; Daida H
Heart Vessels; 2014 Jan; 29(1):35-41. PubMed ID: 23516028
[TBL] [Abstract][Full Text] [Related]
17. Fasting adiponectin is inversely correlated with metabolic syndrome in patients with coronary artery disease.
Wang JH; Lee CJ; Lee CC; Chen YC; Lee RP; Hsu BG
Intern Med; 2010; 49(8):739-47. PubMed ID: 20424363
[TBL] [Abstract][Full Text] [Related]
18. Relationships between the visceral fat area on CT and coronary risk factor markers.
Shiina Y; Homma Y
Intern Med; 2013; 52(16):1775-80. PubMed ID: 23955611
[TBL] [Abstract][Full Text] [Related]
19. Administration of eicosapentaenoic acid may alter lipoprotein particle heterogeneity in statin-treated patients with stable coronary artery disease: A pilot 6-month randomized study.
Tani S; Yagi T; Matsuo R; Kawauchi K; Atsumi W; Matsumoto N; Okumura Y
J Cardiol; 2020 Nov; 76(5):487-498. PubMed ID: 32636128
[TBL] [Abstract][Full Text] [Related]
20. Predictive Value of the Triglyceride to High-Density Lipoprotein Cholesterol Ratio for All-Cause Mortality and Cardiovascular Death in Diabetic Patients With Coronary Artery Disease Treated With Statins.
Wang L; Cong H; Zhang J; Hu Y; Wei A; Zhang Y; Yang H; Ren L; Qi W; Li W
Front Cardiovasc Med; 2021; 8():718604. PubMed ID: 34368266
[No Abstract] [Full Text] [Related]
[Next] [New Search]
